Free Trial

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$14.26 +0.06 (+0.42%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$15.65 +1.39 (+9.75%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$13.81
$15.11
50-Day Range
$11.49
$15.88
52-Week Range
$11.41
$24.18
Volume
2.96 million shs
Average Volume
1.09 million shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 70% of companies evaluated by MarketBeat, and ranked 162nd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside Potential

    Surgery Partners has a consensus price target of $22.00, representing about 54.3% upside from its current price of $14.26.

  • Amount of Analyst Coverage

    Surgery Partners has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 166.67% in the coming year, from $0.09 to $0.24 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -23.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -23.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.58% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 14.13, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Surgery Partners has recently increased by 13.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • News Sentiment

    Surgery Partners has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Surgery Partners this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for SGRY on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,284,058.00 in company stock.

  • Percentage Held by Insiders

    2.70% of the stock of Surgery Partners is held by insiders.

  • Percentage Held by Institutions

    Surgery Partners has minimal institutional ownership at this time.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY stock has decreased by 7.7% and is now trading at $14.26.

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.12. Surgery Partners's revenue was up 4.5% compared to the same quarter last year.
Read the conference call transcript
.

Surgery Partners' Board of Directors initiated a stock repurchase plan on Thursday, February 26th 2026, which allows the company to repurchase $200,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 9.7% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board of directors believes its shares are undervalued.

Surgery Partners (SGRY) raised $350 million in an IPO on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share.

Surgery Partners' top institutional shareholders include Hsbc Holdings PLC (1.46%), Bank of New York Mellon Corp (0.23%), SG Americas Securities LLC (0.20%) and Principal Financial Group Inc. (0.11%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca.
View institutional ownership trends
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
5/05/2026
Today
5/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
16,000
Year Founded
2004

Price Target and Rating

High Price Target
$36.00
Low Price Target
$14.00
Potential Upside/Downside
+54.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
158.44
P/E Growth
N/A
Net Income
-$77.90 million
Net Margins
-2.35%
Pretax Margin
3.53%
Return on Equity
1.28%
Return on Assets
0.51%

Debt

Debt-to-Equity Ratio
1.15
Current Ratio
1.87
Quick Ratio
1.71

Sales & Book Value

Annual Sales
$3.31 billion
Price / Sales
0.56
Cash Flow
$1.71 per share
Price / Cash Flow
8.32
Book Value
$24.21 per share
Price / Book
0.59

Miscellaneous

Outstanding Shares
130,800,000
Free Float
127,266,000
Market Cap
$1.87 billion
Optionable
Optionable
Beta
1.99

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners